FDA Accepts Supplement for ENDOMETRIN by Ferring
The FDA has accepted a supplemental application for ENDOMETRIN, a progesterone-based therapy.
Asset / Drug
Drug and asset intelligence for Ferring with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
Hormonal Therapy
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.